Related Experiment Video
Updated: Feb 24, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Deriving genomic diagnoses without revealing patient genomes
Karthik A Jagadeesh1, David J Wu1, Johannes A Birgmeier1
1Department of Computer Science, Stanford University, Stanford, CA 94305, USA.
Genomic diagnoses for rare diseases are now possible while protecting patient privacy using secure multiparty computation. This method identifies causal variants and new disease genes, safeguarding sensitive genetic information.
Area of Science:
- Genomics
- Bioinformatics
- Computational Biology
Background:
- Interpreting patient genomes requires comparison with other genomes, but sharing raises privacy concerns.
- Numerous monogenic diseases have identified genomic diagnoses and potential therapeutic targets.
Purpose of the Study:
- To demonstrate a privacy-preserving method for genomic diagnosis using secure multiparty computation.
- To enable accurate identification of disease-causing genetic variants while maintaining participant confidentiality.
Main Methods:
- Implementation of secure multiparty computation (SMC) for distributed genomic data analysis.
- Application of SMC in diverse clinical scenarios, including small cohorts, trio analyses, and multi-institutional collaborations.
Main Results:
- Successful identification of causal variants for monogenic diseases in real-world scenarios.
- Discovery of previously unrecognized disease genes and variants.
- Achieved up to 99.7% privacy for participants' sensitive genomic data.
Conclusions:
- Secure multiparty computation offers a viable solution for privacy-preserving genomic diagnosis.
- This approach facilitates collaborative research and accelerates the discovery of genetic disease mechanisms.
- The method balances the need for large-scale genomic data analysis with stringent participant privacy requirements.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Related Concept Videos
Genomics
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Pharmacogenomics: Identification of New Drug Targets
Evolutionary Relationships through Genome Comparisons